- 2024-08-20 01:56抑制剂GS-621763|GS-621763|2647442-13-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:56抑制剂GSK 2830371|GSK 2830371|1404456-53-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:56抑制剂GPR52 antagonist-1|GPR52 antagonist-1|1239987-91-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:56抑制剂GS-6201|GS-6201|752222-83-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:56抑制剂GS-6201|GS-6201|752222-83-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:56抑制剂GOT1 inhibitor-1|GOT1 inhibitor-1|732973-87-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:56抑制剂GOT1 inhibitor-1|GOT1 inhibitor-1|732973-87-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:56抑制剂GPR52 antagonist-1|GPR52 antagonist-1|1239987-91-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:56抑制剂GPR52 antagonist-1|GPR52 antagonist-1|1239987-91-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:56抑制剂GNF-7|GNF-7|839706-07-9|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:56抑制剂GNF-7|GNF-7|839706-07-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:56抑制剂GNF-7|GNF-7|839706-07-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:56抑制剂GOT1 inhibitor-1|GOT1 inhibitor-1|732973-87-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:56抑制剂GNF4877|GNF4877|2041073-22-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:56抑制剂GNF4877|GNF4877|2041073-22-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:56抑制剂GNF4877|GNF4877|2041073-22-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:56抑制剂GNE-131|GNE-131|1629063-81-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:56抑制剂GNE-617|GNE-617|1362154-70-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:56抑制剂GNE-617|GNE-617|1362154-70-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:56抑制剂GNE-617|GNE-617|1362154-70-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
